aspirin and dipyridamole (43598-339)

Drug Facts

Product Profile

Brand Name aspirin and dipyridamole

Generic Name aspirin and dipyridamole

Labeler dr. reddy's laboratories inc

Dosage Form CAPSULE, EXTENDED RELEASE

Routes

ORAL

Active Ingredients

aspirin 25 mg/1, dipyridamole 200 mg/1

Manufacturer

Dr. Reddy's Laboratories Inc

Identifiers & Regulatory

Product NDC 43598-339

Product ID 43598-339_4483f2db-5250-45fd-e1b1-03ffa74a4eb1

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA209048

Listing Expiration 2026-12-31

Marketing Start 2018-10-10

Pharmacologic Class

Established (EPC)

nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]

Mechanism of Action

cyclooxygenase inhibitors [moa]

Chemical Structure

anti-inflammatory agents, non-steroidal [cs]

Physiologic Effect

decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43598339

Hyphenated Format 43598-339

Supplemental Identifiers

RxCUI

259081

UPC

0343598339603

UNII

R16CO5Y76E 64ALC7F90C

NUI

N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin and dipyridamole (source: ndc)

Generic Name aspirin and dipyridamole (source: ndc)

Application Number ANDA209048 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

25 mg/1
200 mg/1

source: ndc

Packaging

60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-339-60)

source: ndc

Packages (1)

43598-339-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-339-60)

Ingredients (2)

aspirin (25 mg/1) dipyridamole (200 mg/1)

Linked Drug Pages (1)

Aspirin and Dipyridamole ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "4483f2db-5250-45fd-e1b1-03ffa74a4eb1", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0343598339603"], "unii": ["R16CO5Y76E", "64ALC7F90C"], "rxcui": ["259081"], "spl_set_id": ["92222dd3-7802-2a03-7d30-58cf192cc33e"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-339-60)", "package_ndc": "43598-339-60", "marketing_start_date": "20181010"}], "brand_name": "Aspirin and Dipyridamole", "product_id": "43598-339_4483f2db-5250-45fd-e1b1-03ffa74a4eb1", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "43598-339", "generic_name": "Aspirin and Dipyridamole", "labeler_name": "Dr. Reddy's Laboratories Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aspirin and Dipyridamole", "active_ingredients": [{"name": "ASPIRIN", "strength": "25 mg/1"}, {"name": "DIPYRIDAMOLE", "strength": "200 mg/1"}], "application_number": "ANDA209048", "marketing_category": "ANDA", "marketing_start_date": "20181010", "listing_expiration_date": "20261231"}